Nektar Therapeutics NKTR
$30.20 −$2.34 (-7.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.20 0.00%
Open$31.66
Prev close$32.54
Day range$30.13 – $32.35
Volume1.02M
Market cap$1.03B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts10
Average target$137.75+356.1% vs. price
- Buy 70%
- Hold 30%
Low $40.00Now $30.20Avg $137.75High $192.00
Recent rating changes
The last 20 actions on file set price targets from $40.00 to $192.00, averaging $151.06.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 13 Nov 2026 | Piper Sandler | BUY | $192.00 |
| 13 Nov 2026 | Wedbush | HOLD | $40.00 |
| 22 Oct 2026 | Piper Sandler | BUY | $192.00 |
| 12 Oct 2026 | UBS | HOLD | $53.00 |
| 12 Oct 2026 | Leerink Partners | BUY | $130.00 |
| 11 Oct 2026 | UBS | HOLD | $53.00 |
| 9 Oct 2026 | BTIG | BUY | $178.00 |
| 8 Oct 2026 | Raymond James | HOLD | – |
| 5 Oct 2026 | Citi | BUY | $151.00 |
| 2 Oct 2026 | H.C. Wainwright | BUY | $185.00 |
| 1 Oct 2026 | William Blair | BUY | – |
| 1 Oct 2026 | Jefferies | BUY | $150.00 |
| 1 Oct 2026 | H.C. Wainwright | BUY | $185.00 |
| 29 Sep 2026 | BTIG | BUY | $178.00 |
| 28 Sep 2026 | CCORF | BUY | $153.00 |
| 25 Sep 2026 | BTIG | BUY | $178.00 |
| 17 Sep 2026 | BTIG | BUY | $178.00 |
| 16 Sep 2026 | BTIG | BUY | $178.00 |
| 20 Aug 2026 | Piper Sandler | BUY | $192.00 |
| 17 Aug 2026 | CCORF | BUY | $153.00 |
No comments yet — be the first to weigh in on NKTR.
Sign in to join the discussion.